Beschreibung

Rekrutierung gestartet

An Open Label, Phase I/II Study to Investigate the Use of Voraxaze™ as Intended Intervention in Patients with Central Nervous System Lymphoma and with Impaired Renal Function being treated with High-Dose Methotrexate

Studienstatus

Rekrutierungsziel erreicht/keine neuen Patienten

Spezifische Infos zum Antrag

Nein